Looking at the life stories of ex-drug misusers in their own words, this book offers insights into the nature of addiction and how it can be tackled. It examines the links between early childhood experiences and drug misuse and also shows pathways to recovery and transformation. Kim Etherington highlights the therapeutic value of listening to drug misusers' life stories and the importance of understanding how social environments and the wider cultural influences shape people's lives. She encourages people working with drug misusers to challenge pathologising notions of 'spoiled identity', whic
Zugriffsoptionen:
Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
"This material was developed by the National Drug Abuse Center for Training and Resource Development, pursuant to Contract Number 271-78-4600"--T.p. verso. ; [1] Trainer manual--[2] Participant manual. ; Mode of access: Internet.
Intro -- Contents -- Preface -- Chapter 1 -- Opioid Treatment Programs and Related Federal Regulations( -- Summary -- Medication-Assisted Treatment (MAT) -- Methadone -- Buprenorphine -- Naltrexone -- Regulatory Framework -- Federal Food, Drug, and Cosmetic Act (FFDCA) -- Controlled Substances Act (CSA) -- Opioid Treatment Programs (OTPs) -- OTP Accreditation -- OTP Certification -- OTP Registration -- DATA-Waived Providers (DWPs) -- Practitioner Requirements -- Medication Requirements -- Chapter 2 -- Increase in Illicit Fentanyl Overdose Deaths* -- Summary -- What Is Fentanyl? -- Rise of Fentanyl Overdoses -- Availability of Fentanyl -- Policy Considerations -- Chapter 3 -- The Opioid Epidemic and the Food and Drug Administration: Legal Authorities and Recent Agency Action( -- Summary -- FDA Approval of Prescription Drugs and the Challenges of Opioids -- FDA Authority and Recent Agency Action Related to the Opioid Epidemic -- Decreasing Exposure and Preventing New Addiction -- Supporting the Treatment of Those with Opioid Use Disorder -- Fostering the Development of Novel Pain Treatment Therapies -- Improving Enforcement and Assessing Benefit Risk -- Selected Opioid-Related Bills in the 115th Congress That Would Amend the FD&C Act -- Chapter 4 -- High Intensity Drug Trafficking Areas (HIDTA) Program( -- Summary -- HIDTA Designations -- Coordination -- Funding -- HIDTA Issues for Consideration -- Unit of Inclusion -- County-Level Drug Trafficking Data -- Criteria for Inclusion -- Program Effectiveness -- Program Scope -- Use of Funds for Treatment and Prevention Initiatives -- Heroin Response Strategy -- HIDTA as an ONDCP Component -- Chapter 5 -- Legal Authorities Under the Controlled Substances Act to Combat the Opioid Crisis( -- Summary -- Brief Background on the Opioid Epidemic -- Overview of the CSA
Zugriffsoptionen:
Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
Intro -- Introduction -- 1. An Overview of Drug Abuse and Dependence -- 2. Drug Abusers Are Often Victims of a Mental Illness -- 3. People Are Responsible for Their Decision to Abuse Drugs -- 4. Social and Environmental Conditions Cause Drug Addiction -- 5. Drug War Madness -- 6. All Drugs Should Be Legalized -- 7. Effective Education Programs Are Successful in Preventing Drug Abuse -- 8. Spiritual Meaning Is Needed to Combat Drug Abuse -- 9. Straightening the Irish Out About Addiction -- 10. Prescription Drug Abuse Is a Growing Problem -- 11. Attempts to Prevent People from Abusing Prescription Drugs Are Harming Legitimate Users -- 12. A Teenage Girl Describes Her Experience with Heroin Addiction -- Appendix -- Organizations to Contact -- Bibliography -- Index -- Picture Credits -- 1 -- 3 -- 5 -- 6 -- 7
Zugriffsoptionen:
Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
This book offers a frank, clear-eyed, no-holes-barred examination of drug abuse-from the most commonly abused drugs to how drug abuse begins and progresses to the dangerous and deadly consequences of drug abuse. It also charts the treacherous path by which "casual" drug use develops into addiction. Loaded with great questions to ask a drug counselor, common myths and facts about drug use and abuse, and resources for getting help for oneself or loved ones, this book is a potentially lifesaving aid and wakeup call for teens in peril, especially those who don't yet realize they're in peril
Zugriffsoptionen:
Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
Intro -- One Living Life To Do More Drugs -- Two Triggers And Thypical Warning Signs -- Three The Harm In Getting High -- Four An issue THat Impacts Relationships -- Five Getting Clean And Staying Sober -- Six Teens' Ideas on Tackling Drug Abuse -- Notes -- Glossary -- Further information -- Bibliography -- Index
Zugriffsoptionen:
Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
Is there a drug abuse crisis? -- Teen drug abuse is a national crisis / Meredith Maran -- A teen drug abuse crisis does not exist / Drug Reform Coordination Network -- Methamphetamine abuse is a crisis in the United States / National Association of Counties -- Methamphetamine abuse is not a crisis in the United States / Steve Chapman -- Prescription drug abuse is reaching crisis proportions / Joseph Califano -- How can drug abuse be reduced? -- The war on drugs reduces drug abuse / Jonathan V. Last -- The war on drugs does not reduce drug abuse / Jack Cole -- Legalizing drugs would increase drug abuse / U.S. Drug Enforcement Agency -- Legalizing drugs would reduce drug abuse / Norm Stamper -- Student drug testing reduces drug abuse / Calvina L. Fay -- Student drug testing does not reduce drug abuse / Nikos A. Leverenz -- What role does marijuana play in drug abuse? -- Marijuana is harmful / U.S. Office of Drug Control Policy -- Marijuana is not harmful / Paul Armentano -- Marijuana use leads to abuse of other drugs / National Center on Substance Abuse and Addiction at Columbia University -- Marijuana use does not lead to abuse of other drugs / Common Sense for Drug Policy -- Facts about drug abuse -- Organizations to contact
Cover Page -- Title Page -- Copyright Page -- Contents -- Foreword -- Introduction: The National Tragedy of Drug Abuse -- Chapter One: Drug Abuse in America -- Chapter Two: How Drugs Affect the Brain, the Body, and Behavior -- Chapter Three: How Drug Abuse Affects Society -- Chapter Four: The War on Drugs -- Chapter Five: Should Drugs Be Legalized? -- Notes -- Discussion Questions -- Organizations to Contact -- For More Information -- Index -- Picture Credits -- About the Author -- Back Cover
Zugriffsoptionen:
Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
<i>Background/Aim:</i> In recent years, there has been a growing interest in developing adequate treatments for patients with a diagnosis of schizophrenia and a comorbid substance use disorder (SUD). In the present paper we aim to critically review published reports on the use of conventional and second-generation antipsychotics in the treatment of patients with schizophrenia and comorbid SUD, to provide clinicians with a clearer view of the pharmacological treatment of this highly prevalent dual diagnosis based upon the evidence arising from the scientific literature. <i>Methods:</i> A search of the relevant literature from Medline, PsycLIT and EMBASE databases, included in the Science Citation Index, and available up to November 2006 was conducted using the terms: 'schizophrenia', 'substance use disorder' and 'antipsychotics'. <i>Results:</i> While research on the use of conventional antipsychotics has remained limited, the majority of studies suggest the effectiveness of second-generation antipsychotics, particularly clozapine, for patients with schizophrenia and a comorbid substance use disorder. <i>Conclusion:</i> In the absence of randomized controlled trials that could provide more reliable information, clinical decisions may need to rely on indirect data provided by the increasing number of case reports, open trials and retrospective studies showing a decrease in cigarette smoking, alcohol, cocaine or cannabis use and an improvement of overall psychiatric symptoms.